Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-029858

CEO sold 200,000 shares at an average $46.02 ($9,204,692)

  • CEO acquired 200,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DAVIS STEPHEN CEO 2020-05-13 Option exercise +111,458 $19.65 $2,190,150 123,267 D
DAVIS STEPHEN CEO 2020-05-13 Sale −13,908 $48.98 $681,244 109,359 D
DAVIS STEPHEN CEO 2020-05-13 Sale −5,205 $48.60 $252,953 104,154 D
DAVIS STEPHEN CEO 2020-05-13 Sale −20,756 $46.43 $963,705 83,398 D
DAVIS STEPHEN CEO 2020-05-13 Sale −63,392 $45.71 $2,897,858 20,006 D
DAVIS STEPHEN CEO 2020-05-13 Sale −8,197 $45.12 $369,827 11,809 D
DAVIS STEPHEN CEO 2020-05-14 Option exercise +88,542 $19.65 $1,739,850 100,351 D
DAVIS STEPHEN CEO 2020-05-14 Sale −84,221 $45.65 $3,844,596 16,130 D
DAVIS STEPHEN CEO 2020-05-14 Sale −4,321 $45.01 $194,509 11,809 D
Derivatives
DAVIS STEPHEN CEO 2020-05-13 Option exercise · Stock Option (Right to Buy) −111,458 188,542 D
DAVIS STEPHEN CEO 2020-05-14 Option exercise · Stock Option (Right to Buy) −88,542 100,000 D
Open-market sales · 200,000 sh · avg $46.02 · $9,204,692
Loading xslF345X03/doc4.xml…